Your browser doesn't support javascript.
loading
Visualization of HER2-specific breast cancer intratumoral heterogeneity using 64Cu-DOTA-trastuzumab PET.
Sasada, Shinsuke; Kurihara, Hiroaki; Kinoshita, Takayuki; Yoshida, Masayuki; Honda, Natsuki; Shimoi, Tatsunori; Shimomura, Akihiko; Yonemori, Kan; Shimizu, Chikako; Hamada, Akinobu; Kanayama, Yousuke; Watanabe, Yasuyoshi; Fujiwara, Yasuhiro; Tamura, Kenji.
Affiliation
  • Sasada S; Department of Breast and Medical Oncology, National Cancer Center Hospital, Tsukiji 5-1-1, Chuo-Ku, Tokyo, 104-0045, Japan.
  • Kurihara H; Surgical Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan.
  • Kinoshita T; Department of Diagnostic Radiology, National Cancer Center Hospital, Tokyo, Japan.
  • Yoshida M; Department of Breast Surgery, National Cancer Center Hospital, Tokyo, Japan.
  • Honda N; Department of Pathology and Clinical Laboratories, National Cancer Center Hospital, Tokyo, Japan.
  • Shimoi T; Department of Diagnostic Radiology, National Cancer Center Hospital, Tokyo, Japan.
  • Shimomura A; Department of Breast and Medical Oncology, National Cancer Center Hospital, Tsukiji 5-1-1, Chuo-Ku, Tokyo, 104-0045, Japan.
  • Yonemori K; Department of Breast and Medical Oncology, National Cancer Center Hospital, Tsukiji 5-1-1, Chuo-Ku, Tokyo, 104-0045, Japan.
  • Shimizu C; Department of Breast and Medical Oncology, National Cancer Center Hospital, Tsukiji 5-1-1, Chuo-Ku, Tokyo, 104-0045, Japan.
  • Hamada A; Department of Breast and Medical Oncology, National Cancer Center Hospital, Tsukiji 5-1-1, Chuo-Ku, Tokyo, 104-0045, Japan.
  • Kanayama Y; Division of Molecular Pharmacology and Pharmacokinetics, National Cancer Center Research Institute, Tokyo, Japan.
  • Watanabe Y; RIKEN Center for Life Science Technologies, Hyogo, Japan.
  • Fujiwara Y; RIKEN Center for Life Science Technologies, Hyogo, Japan.
  • Tamura K; Department of Breast and Medical Oncology, National Cancer Center Hospital, Tsukiji 5-1-1, Chuo-Ku, Tokyo, 104-0045, Japan.
Eur J Nucl Med Mol Imaging ; 44(12): 2146-2147, 2017 11.
Article in En | MEDLINE | ID: mdl-28770275
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Organometallic Compounds / Breast Neoplasms / Receptor, ErbB-2 / Positron-Emission Tomography / Antibodies, Monoclonal, Humanized Limits: Female / Humans / Middle aged Language: En Journal: Eur J Nucl Med Mol Imaging Journal subject: MEDICINA NUCLEAR Year: 2017 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Organometallic Compounds / Breast Neoplasms / Receptor, ErbB-2 / Positron-Emission Tomography / Antibodies, Monoclonal, Humanized Limits: Female / Humans / Middle aged Language: En Journal: Eur J Nucl Med Mol Imaging Journal subject: MEDICINA NUCLEAR Year: 2017 Document type: Article Affiliation country: Country of publication: